Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Avricore Health (AVCRF) Gross Margin (2016 - 2025)

Avricore Health has reported Gross Margin over the past 11 years, most recently at 21.84% for Q4 2025.

  • Quarterly Gross Margin fell 6336.0% to 21.84% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 43.56% through Dec 2025, up 427.0% year-over-year, with the annual reading at 44.63% for FY2025, 534.0% up from the prior year.
  • Gross Margin was 21.84% for Q4 2025 at Avricore Health, up from 139.6% in the prior quarter.
  • Over five years, Gross Margin peaked at 79.78% in Q1 2025 and troughed at 167.63% in Q2 2025.
  • The 5-year median for Gross Margin is 29.87% (2023), against an average of 10.56%.
  • Year-over-year, Gross Margin soared 5249bps in 2022 and then crashed -20310bps in 2025.
  • A 5-year view of Gross Margin shows it stood at 26.48% in 2021, then crashed by -35bps to 17.28% in 2022, then soared by 114bps to 37.02% in 2023, then grew by 12bps to 41.51% in 2024, then tumbled by -153bps to 21.84% in 2025.
  • Per Business Quant, the three most recent readings for AVCRF's Gross Margin are 21.84% (Q4 2025), 139.6% (Q3 2025), and 167.63% (Q2 2025).